we could quickly run to $ 4
Recent OGEN News
- Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation • GlobeNewswire Inc. • 03/25/2026 10:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/23/2026 04:15:07 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/19/2026 09:24:57 PM
- ORAGENICS FILES ANNUAL REPORT ON FORM 10-K • GlobeNewswire Inc. • 03/17/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 08:30:41 PM
- ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION • GlobeNewswire Inc. • 03/12/2026 12:30:00 PM
- ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION • GlobeNewswire Inc. • 03/11/2026 12:30:00 PM
- Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia • GlobeNewswire Inc. • 03/10/2026 12:30:00 PM
- Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy • GlobeNewswire Inc. • 02/09/2026 01:30:00 PM
- Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care • GlobeNewswire Inc. • 02/02/2026 01:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2026 09:11:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:05:42 PM
- Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico • GlobeNewswire Inc. • 01/14/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:55:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:49:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:38:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:25:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:19:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 09:05:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 11:28:44 PM
- Oragenics Q3 2025 Shareholder Update • Business Wire • 11/12/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:15:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:06:17 PM
